Skip to main content
. 2018 Nov 18;2018:8485670. doi: 10.1155/2018/8485670

Figure 2.

Figure 2

Cell availability test of B16-F10 after subjecting to different concentrations of apigenin-7-butylene glucoside ( implies differences at p<0.005; ∗∗ implies significant differences at p<0.001).

HHS Vulnerability Disclosure